You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 115 No. 8, August 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Ototoxicity of Ceftazidime in the Chinchilla Middle Ear

Orval E. Brown, MD; Charles G. Wright, PhD; Laura B. Edwards; William L. Meyerhoff, MD, PhD

Arch Otolaryngol Head Neck Surg. 1989;115(8):940-942.


Abstract

• Ceftazidime (Tazicef) is a broad-spectrum cephalosporin antibiotic that may be useful as a topical agent in the treatment of otorrhea. To test the potential ototoxicity of the drug, 0.5 mL of a 10% solution of ceftazidime was introduced into the bullae of 22 chinchillas. The organ of Corti was normal in 20 temporal bones examined at 1 week after administration of the ceftazidime solution. Only 2 of 24 temporal bones examined after 4 weeks showed minor outer hair cell loss of the basal turn of the organ of Corti. Focal hemorrhage and occasional serous effusions were found in the middle ears of all animals after 1 week; these findings had mostly cleared after 4 weeks. Our results indicate that ceftazidime causes reversible middle ear inflammation, and may have some minor ototoxic potential under these experimental conditions.

(Arch Otolaryngol Head Neck Surg. 1989;115:940-942)



Author Affiliations

From the Department of Otolaryngology, University of Texas Southwestern Medical Center at Dallas.


Footnotes

Accepted for publication February 1, 1989.

Presented in part at the Society for Ear, Nose, and Throat Advances in Children, New York, NY, December 9, 1988.

Reprint requests to Department of Otolaryngology, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, Dallas, TX 75235-9035 (Dr Brown).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Ototoxicity of Topical Ticarcillin and Clavulanic Acid in the Chinchilla
Jakob et al.
Arch Otolaryngol Head Neck Surg 1995;121:39-43.
ABSTRACT  

Ciprofloxacin: Use as a Topical Otic Preparation
Brownlee et al.
Arch Otolaryngol Head Neck Surg 1992;118:392-396.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.